Ephedrine is commonly used as a stimulant, appetite suppressant, concentration aid, and decongestant, and weight loss aid. A number of adverse effects associated with ephedrine alkaloid-containing dietary supplements have been reported to the FDA.
These include elevated blood pressure, rapid heartbeat, nerve damage, muscle injury, and psychosis and memory loss. More serious effects have also been reported, including heart attack, stroke, seizure and death.
This recall affects all lot codes and use by dates of EphBurn 25. The product is a 90-count bottle with red capsules and prominently displays the product name 'ephBURN 25' in white letters on the front of a red label. EphBurn 25 was previously discontinued on or about May of 2012.
The product was distributed to various retail stores nationwide, and was sold via the Internet from the period of time of approximately April 2010 through August 2012. No other products distributed by BNE are subject to recall.
There have been no reports of adverse events associated with this recalled product.
Consumers who may have purchased EphBurn 25 have been asked to immediately discontinue using the product and contact their health care professional if they have experienced any adverse effects.
